Lv1
50 积分 2024-03-14 加入
Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report
14天前
已完结
Postgastrectomy pharmacokinetic changes of S‐1 in patients with localized advanced gastric cancer
14天前
已完结
Pharmacokinetic and bioequivalence study of new S-1 capsule in Chinese cancer patients
14天前
已完结
Improved method for quantification of intact oxaliplatin by ultra high performance liquid chromatography-inductively coupled plasma mass spectrometry: Applications to clinical and speciation studies
15天前
已完结
An optimized HPLC-MS/MS assay for uracil and dihydrouracil in plasma: Improving dihydropyrimidine dehydrogenase phenotyping for individualized fluoropyrimidine treatment
21天前
已完结
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors
21天前
已关闭
Determination of 5-Fluorouracil and Its Prodrug Tegafur in Plasma and Tissue by High-Performance Liquid Chromatography in a Single Injection: Validation for Application in Clinical Pharmacokinetic Studies
21天前
已完结
Sensitive MS/MS–liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma
21天前
已完结
Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography–tandem mass spectrometry
21天前
已完结
Comparison of three derivatization reagents for the simultaneous determination of highly hydrophilic pyrimidine antitumor agents in human plasma by LC–MS/MS
23天前
已完结
皖公网安备34019202002308
